Class information for: |
Basic class information |
| ID | Publications | Average number of references |
Avg. shr. active ref. in WoS |
|---|---|---|---|
| 18266 | 495 | 37.6 | 94% |
Classes in level above (level 2) |
Terms with highest relevance score |
| Rank | Term | Type of term | Relevance score (tfidf) |
Class's shr. of term's tot. occurrences |
Shr. of publ. in class containing term |
Num. of publ. in class |
|---|---|---|---|---|---|---|
| 1 | TIM 3 | Author keyword | 116 | 73% | 18% | 88 |
| 2 | GALECTIN 9 | Author keyword | 36 | 50% | 11% | 52 |
| 3 | TIM 1 | Author keyword | 34 | 63% | 7% | 34 |
| 4 | IMMUNOL IMMUNOPATHOL | Address | 16 | 28% | 10% | 49 |
| 5 | TIM 4 | Author keyword | 8 | 75% | 1% | 6 |
| 6 | TIM3 | Author keyword | 7 | 67% | 1% | 6 |
| 7 | GAL 9 | Author keyword | 6 | 100% | 1% | 4 |
| 8 | T CELL IMMUNOGLOBULIN AND MUCIN DOMAIN CONTAINING MOLECULE 3 | Author keyword | 6 | 100% | 1% | 4 |
| 9 | GALPHARMA CO LTD | Address | 4 | 75% | 1% | 3 |
| 10 | HAVCR 1 | Author keyword | 4 | 75% | 1% | 3 |
Web of Science journal categories |
Author Key Words |
| Rank | Web of Science journal category | Relevance score (tfidf) |
Class's shr. of term's tot. occurrences |
Shr. of publ. in class containing term |
Num. of publ. in class |
LCSH search | Wikipedia search |
|---|---|---|---|---|---|---|---|
| 1 | TIM 3 | 116 | 73% | 18% | 88 | Search TIM+3 | Search TIM+3 |
| 2 | GALECTIN 9 | 36 | 50% | 11% | 52 | Search GALECTIN+9 | Search GALECTIN+9 |
| 3 | TIM 1 | 34 | 63% | 7% | 34 | Search TIM+1 | Search TIM+1 |
| 4 | TIM 4 | 8 | 75% | 1% | 6 | Search TIM+4 | Search TIM+4 |
| 5 | TIM3 | 7 | 67% | 1% | 6 | Search TIM3 | Search TIM3 |
| 6 | GAL 9 | 6 | 100% | 1% | 4 | Search GAL+9 | Search GAL+9 |
| 7 | T CELL IMMUNOGLOBULIN AND MUCIN DOMAIN CONTAINING MOLECULE 3 | 6 | 100% | 1% | 4 | Search T+CELL+IMMUNOGLOBULIN++AND+MUCIN+DOMAIN+CONTAINING+MOLECULE+3 | Search T+CELL+IMMUNOGLOBULIN++AND+MUCIN+DOMAIN+CONTAINING+MOLECULE+3 |
| 8 | HAVCR 1 | 4 | 75% | 1% | 3 | Search HAVCR+1 | Search HAVCR+1 |
| 9 | TIM1 | 3 | 50% | 1% | 5 | Search TIM1 | Search TIM1 |
| 10 | HEPATITIS A VIRUS CELLULAR RECEPTOR 1 | 3 | 100% | 1% | 3 | Search HEPATITIS+A+VIRUS+CELLULAR+RECEPTOR+1 | Search HEPATITIS+A+VIRUS+CELLULAR+RECEPTOR+1 |
Key Words Plus |
| Rank | Web of Science journal category | Relevance score (tfidf) |
Class's shr. of term's tot. occurrences |
Shr. of publ. in class containing term |
Num. of publ. in class |
|---|---|---|---|---|---|
| 1 | MUCIN DOMAIN | 72 | 91% | 6% | 30 |
| 2 | TIM 3 | 60 | 59% | 13% | 66 |
| 3 | GALECTIN 9 | 44 | 66% | 8% | 41 |
| 4 | EXON 4 VARIATIONS | 41 | 100% | 3% | 15 |
| 5 | T CELL IMMUNOGLOBULIN | 33 | 83% | 4% | 19 |
| 6 | TIM GENE FAMILY | 25 | 60% | 6% | 28 |
| 7 | RECEPTOR TIM 3 | 21 | 90% | 2% | 9 |
| 8 | CONTAINING MOLECULE 3 TIM 3 | 20 | 100% | 2% | 9 |
| 9 | TIM 3 LIGAND | 13 | 67% | 2% | 12 |
| 10 | SURFACE GENE TIM 3 | 11 | 100% | 1% | 6 |
Journals |
Reviews |
| Title | Publ. year | Cit. | Active references | % act. ref. to same field |
|---|---|---|---|---|
| Tim-3: an activation marker and activation limiter of innate immune cells | 2013 | 18 | 41 | 80% |
| TIM genes: a family of cell surface phosphatidylserine receptors that regulate innate and adaptive immunity | 2010 | 126 | 105 | 64% |
| The costimulatory role of TIM molecules | 2009 | 86 | 75 | 68% |
| TIM-3 and Its Regulatory Role in Immune Responses | 2011 | 31 | 52 | 69% |
| Emerging Tim-3 functions in antimicrobial and tumor immunity | 2011 | 49 | 52 | 48% |
| The Emerging Role of the TIM Molecules in Transplantation | 2011 | 14 | 48 | 81% |
| Tim-3, a negative regulator of anti-tumor immunity | 2012 | 39 | 27 | 37% |
| Novel roles for TIM-1 in immunity and infection | 2011 | 16 | 38 | 71% |
| Too Much of a Good Thing? Tim-3 and TCR Signaling in T Cell Exhaustion | 2014 | 5 | 57 | 39% |
| TIM polymorphisms-genetics and function | 2011 | 11 | 52 | 79% |
Address terms |
| Rank | Address term | Relevance score (tfidf) |
Class's shr. of term's tot. occurrences |
Shr. of publ. in class containing term |
Num. of publ. in class |
|---|---|---|---|---|---|
| 1 | IMMUNOL IMMUNOPATHOL | 16 | 28% | 9.9% | 49 |
| 2 | GALPHARMA CO LTD | 4 | 75% | 0.6% | 3 |
| 3 | HEPATITIS HCV HIV PROGRAM | 4 | 56% | 1.0% | 5 |
| 4 | HOLIST IMMUNOL | 3 | 100% | 0.6% | 3 |
| 5 | RUMENT EQUIPMENT | 3 | 50% | 0.8% | 4 |
| 6 | DISASTER RELATED INFECT DIS | 2 | 40% | 0.8% | 4 |
| 7 | MOL DISCOVERY IMMUNOBIOL | 1 | 100% | 0.4% | 2 |
| 8 | NEUROL DISBRIGHAM WOMENS HOSP | 1 | 30% | 0.6% | 3 |
| 9 | GENOME IMMUNE DISORDERS | 1 | 15% | 1.2% | 6 |
| 10 | DUMONT UCLA TRANSPLANT LIVER PANCREAS T | 1 | 23% | 0.6% | 3 |
Related classes at same level (level 1) |
| Rank | Relatedness score | Related classes |
|---|---|---|
| 1 | 0.0000132326 | B7 H4//PD 1//PD L1 |
| 2 | 0.0000105426 | GALECTIN 3//GALECTIN//GALECTIN 1 |
| 3 | 0.0000068001 | MFG E8//APOPTOTIC CELLS//CELL CLEARANCE |
| 4 | 0.0000065868 | LEUKEMIA STEM CELLS//EXPT THER EUT TRANSLAT ONCOL PROGRAM//LEUKEMIC STEM CELL |
| 5 | 0.0000048937 | NEUTROPHIL GELATINASE ASSOCIATED LIPOCALIN//NGAL//LIPOCALIN 2 |
| 6 | 0.0000048704 | REGULATORY B CELLS//CD40 ACTIVATED B CELLS//REGULATORY B CELL |
| 7 | 0.0000040763 | WIG 1//OSTEOACTIVIN//GPNMB |
| 8 | 0.0000039627 | IL 17//INTERLEUKIN 17//TH17 |
| 9 | 0.0000038886 | T BET//GATA 3//HELPER T CELL DIFFERENTIATION |
| 10 | 0.0000038822 | HYGIENE HYPOTHESIS//ATOPIC SENSITIZATION//FARM MILK |